Effect of intermittent fasting on C-reactive protein and calprotectin levels in a Patient with Ulcerative Colitis. A case report
DOI:
https://doi.org/10.56294/saludcyt20241021Keywords:
Ulcerative Colitis, C-Reactive Protein, Fecal CalprotectinAbstract
Introduction: ulcerative colitis is a disease whose causes are multifactorial. Current therapies, such as monoclonal antibodies, present risks, prompting the search for non-pharmacological alternatives such as intermittent fasting. To detect inflammatory conditions, the levels of calprotectin and C-reactive protein are measured.
Objective: to evaluate the effects of intermittent fasting in a 34-year-old patient with ulcerative colitis, on the inflammatory markers fecal calprotectin and C-reactive protein (CRP).
Clinical case: 34-year-old Caucasian woman diagnosed with ulcerative colitis in remission, she participated in an 8-week pilot study on intermittent fasting. After the intervention, it was observed that there were no significant changes in her PRC levels, however, calprotectin increased from 15 mg/kg to 1279 mg/kg, indicating an inflammatory bowel condition in the initial stage given that the patient was asymptomatic.
Conclusions: calprotectin determination is a more appropriate marker to identify intestinal inflammation in early stages. Intermittent fasting could be a complementary therapeutic strategy to extend the periods of symptom remission in this disease
References
1. Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 2021; 18: 56–66. DOI: 10.1038/s41575-020-00360-x
2. Cavalu S, Sharaf H, Saber S,Youssef ME, Abdelhamid AM, Mourad AAE, Ibrahim S, Allam S, Elgharabawy RM, El-Ahwany E, Noha AA, Shata A, Mai E, Atef M,Aboraya M, Mohamed M. Ambroxol, a mucolytic agent, boosts HO-1, suppresses NF-kB, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitis. FASEB J. 2022; 36: e22496. DOI: 10.1096/fj.202200749R.
3. Gubatan J, Kulkarni CV, Talamantes SM, Temby M, Fardeen T, Sinha SR. Dietary Exposures and Interventions in Inflammatory Bowel Disease: Current Evidence and Emerging Concepts. Nutrients 2023; 15: 579. DOI: 10.3390/nu15030579
4. Ng S, Shi H, Hamidi N, et al. Worldwide incidence and pre- valence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet. 2017;390:2769-78
5. Bellolio F, Gómez J, Cerda J. Increase in hospital discharges for inflammatory bowel diseases in chile between 2001 and 2012. Dig Dis Sci 2017;62:2311-7
6. Clark-Snustad K, Butnariu M, Afzali A. Women’s health and ulcerative colitis. Gastroenterol Clin North Am 2020;49:769–89. DOI: 10.1016/j.gtc.2020.07.004
7. Vasconcelos AR, Yshii LM, Viel TA, Buck HS, Mattson MP, Scavone C, Kawamoto EM. Intermittent fasting attenuates lipopolysaccharide-induced neuroinflammation and memory impairment. J. Neuroinflamm. 2014; 11: 85.
8. Negm M, Bahaa A, Farrag, A.; Lithy, R.M.; Badary, H.A.; Essam, M.; Kamel, S.; Sakr, M.; Abd El Aaty,W.; Shamkh, M.; et al. Effect of Ramadan intermittent fasting on inflammatory markers, disease severity, depression, and quality of life in patients with inflammatory bowel diseases: A prospective cohort study. BMC Gastroenterol. 2022; 22: 203. DOI: 10.1186/s12876-022-02272-3
9. Gutierrez-Casbas A. Utilidad del marcador serológico proteína C reactiva en la enfermedad inflamatoria intestinal. Gastroenterol Hepatol Contin 2007; 6:282–5. DOI: 10.1016/S1578-1550(07)75698-X
10. Singh S, Ananthakrishnan AN, Nguyen NH, Cohen BL, Velayos FS, Weiss JM, Sultan S, Siddique SM, Adler J, Chachu KA. AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis. Gastroenterology. 2023; 164(3): 344–372. DOI: 10.1053/j.gastro.2022.12.007
11. Carvajal V, Marín A, Gihardo D, Maluenda F, Carrasco F, Chamorro R.El ayuno intermitente y sus efectos en la salud metabólica en humanos. Revista médica de Chile. 2023, 151(1), 81-100. https://dx.doi.org/10.4067/s0034-98872023000100081
12. Mushtaq R, Akram A, Mushtaq R, Khwaja S, Ahmed S. The role of inflammatory markers following Ramadan Fasting. Pak. J. Med. Sci. 2019, 35, 77–81. DOI: 10.12669/pjms.35.1.95
13. Roco-Videla Á, Villota-Arcos C, Pino-Astorga C, Mendoza-Puga D, Bittner-Ortega M, Corbeaux-Ascui T. Intermittent fasting and reduction of inflammatory response in a patient with ulcerative colitis. Medicina (Kaunas) [Internet]. 2023;59(8):1453. DOI: 10.3390/medicina59081453
Published
Issue
Section
License
Copyright (c) 2024 Claudio Villota-Arcos, Angel Roco-Videla, Carolina Pino-Astorga, Daniela Mendoza-Puga, Mauricio Bittner , Tatiana Corbeaux-Ascui , Raúl Aguilera-Eguia (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
